Hi @rso, I searched Connect and could not find a member discussing Lutetium-177-PSMA-617. I think that's mainly because it's a new treatment only recently being approved on March 23, 2022. It sounds like this could be a beneficial teatment for many patients with advanced prostrate cancer.

-- Breaking News: First-in-Class Radioligand Therapy Approved for Advanced Prostate Cancer: https://www.pcf.org/c/breaking-news-first-in-class-radioligand-therapy-approved-for-advanced-prostate-cancer/

Have you discussed the possibility of the treatment with your care team?